{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T22:23:22Z","timestamp":1787696602188,"version":"build-2784847793"},"publisher-location":"New York, NY","reference-count":33,"publisher":"Springer US","isbn-type":[{"value":"9781071650714","type":"print"},{"value":"9781071650721","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-1-0716-5072-1_17","type":"book-chapter","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T22:03:23Z","timestamp":1787695403000},"page":"417-432","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The High-Throughput C-Circle Assay for Identifying Modulators of Alternative Lengthening of Telomeres(ALT) Activity"],"prefix":"10.1007","author":[{"given":"Merrill M.","family":"Froney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara T.","family":"Ledeboer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael B.","family":"Jarstfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha G.","family":"Pattenden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,2]]},"reference":[{"key":"17_CR1","doi-asserted-by":"publisher","first-page":"5032","DOI":"10.1016\/S0092-8674(00)80760-6","volume":"97","author":"JD Griffith","year":"1999","unstructured":"Griffith JD, Comeau L, Rosenfield S et al (1999) Mammalian telomeres end in a large duplex loop. Cell 97:5032\u20135514","journal-title":"Cell"},{"key":"17_CR2","doi-asserted-by":"crossref","unstructured":"Harley CB, Vaziri H, Counter CM, Allsopp RC (1992) The telomere hypothesis of cellular aging. Exp Gerontol. 27(4):375\u2013382","DOI":"10.1016\/0531-5565(92)90068-B"},{"key":"17_CR3","doi-asserted-by":"crossref","unstructured":"Jafri MA, Ansari SA, Alqahtani MH, Shay JW (2016) Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies. Genome Med 8(1):69","DOI":"10.1186\/s13073-016-0324-x"},{"key":"17_CR4","doi-asserted-by":"crossref","unstructured":"Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57\u201370","DOI":"10.1016\/S0092-8674(00)81683-9"},{"key":"17_CR5","doi-asserted-by":"publisher","first-page":"22568","DOI":"10.1074\/jbc.M000622200","volume":"275","author":"K Masutomi","year":"2000","unstructured":"Masutomi K, Kaneko S, Hayashi N et al (2000) Telomerase activity reconstituted in vitro with purified human telomerase reverse transcriptase and human telomerase RNA component. J\u00a0Biol Chem 275:22568\u201322573. https:\/\/doi.org\/10.1074\/jbc.M000622200","journal-title":"J Biol Chem"},{"key":"17_CR6","doi-asserted-by":"crossref","unstructured":"Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, Harley CB, Shay JW, Lichtsteiner S, Wright WE (1998) Extension of life-span by introduction of telomerase into normal human cells. Science 279(5349):349-52","DOI":"10.1126\/science.279.5349.349"},{"key":"17_CR7","doi-asserted-by":"crossref","unstructured":"Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, Shay JW (1994) Specific association of human telomerase activity with immortal cells and cancer. Science 266(5193):2011\u20135.","DOI":"10.1126\/science.7605428"},{"key":"17_CR8","doi-asserted-by":"publisher","unstructured":"Greider CW, Blackburn EH (1985) Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 43(2 Pt 1):405-13. https:\/\/doi.org\/10.1016\/0092-8674(85)90170-9. PMID: 3907856","DOI":"10.1016\/0092-8674(85)90170-9"},{"key":"17_CR9","doi-asserted-by":"publisher","unstructured":"Hakobyan M, Binder H, Arakelyan A (2024) Pan-cancer analysis of telomere maintenance mechanisms. J Biol Chem 300. https:\/\/doi.org\/10.1016\/j.jbc.2024.107392","DOI":"10.1016\/j.jbc.2024.107392"},{"key":"17_CR10","doi-asserted-by":"crossref","unstructured":"Dunham MA, Neumann AA, Fasching CL, Reddel RR (2000) Telomere maintenance by recombination in human cells. Nat Genet 26(4):447-50","DOI":"10.1038\/82586"},{"key":"17_CR11","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1093\/hmg\/ddn436","volume":"18","author":"A Muntoni","year":"2009","unstructured":"Muntoni A, Neumann AA, Hills M, Reddel RR (2009) Telomere elongation involves intra-molecular DNA replication in cells utilizing alternative lengthening of telomeres. Hum Mol Genet 18:1017\u20131027. https:\/\/doi.org\/10.1093\/hmg\/ddn436","journal-title":"Hum Mol Genet"},{"key":"17_CR12","doi-asserted-by":"crossref","unstructured":"Draskovic I, Londono Vallejo A (2013) Telomere recombination and alternative telomere lengthening mechanisms. Front Biosci (Landmark Ed) 18(1):1-20","DOI":"10.2741\/4084"},{"key":"17_CR13","doi-asserted-by":"publisher","first-page":"3765","DOI":"10.1038\/onc.2009.238","volume":"28","author":"K Lafferty-Whyte","year":"2009","unstructured":"Lafferty-Whyte K, Cairney CJ, Will MB et al (2009) A gene expression signature classifying telomerase and ALT immortalization reveals an hTERT regulatory network and suggests a mesenchymal stem cell origin for ALT. Oncogene 28:3765\u20133774. https:\/\/doi.org\/10.1038\/onc.2009.238","journal-title":"Oncogene"},{"key":"17_CR14","doi-asserted-by":"publisher","first-page":"3790","DOI":"10.1200\/JCO.2004.03.043","volume":"22","author":"RP Sanders","year":"2004","unstructured":"Sanders RP, Drissi R, Billups CA et al (2004) Telomerase expression predicts unfavorable outcome in osteosarcoma. J Clin Oncol 22:3790\u20133797. https:\/\/doi.org\/10.1200\/JCO.2004.03.043","journal-title":"J Clin Oncol"},{"key":"17_CR15","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.ccr.2012.08.024","volume":"22","author":"D Sturm","year":"2012","unstructured":"Sturm D, Witt H, Hovestadt V et al (2012) Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell 22:425\u2013437. https:\/\/doi.org\/10.1016\/j.ccr.2012.08.024","journal-title":"Cancer Cell"},{"key":"17_CR16","doi-asserted-by":"publisher","first-page":"2544","DOI":"10.1016\/j.celrep.2017.05.087","volume":"19","author":"RA Dagg","year":"2017","unstructured":"Dagg RA, Pickett HA, Neumann AA et al (2017) Extensive proliferation of human cancer cells with ever-shorter telomeres. Cell Rep 19:2544\u20132556. https:\/\/doi.org\/10.1016\/j.celrep.2017.05.087","journal-title":"Cell Rep"},{"key":"17_CR17","doi-asserted-by":"crossref","unstructured":"Kent T, Gracias D, Shepherd S, Clynes D (2020) Alternative lengthening of telomeres in pediatric cancer: mechanisms to therapies. Front Oncol 9:1518","DOI":"10.3389\/fonc.2019.01518"},{"key":"17_CR18","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1200\/JCO.2017","volume":"35","author":"D Sturm","year":"2017","unstructured":"Sturm D, Pfister SM, Jones DTW (2017) Pediatric gliomas: current concepts on diagnosis, biology, and clinical management. J\u00a0Clin Oncol 35:2370\u20132377. https:\/\/doi.org\/10.1200\/JCO.2017","journal-title":"J Clin Oncol"},{"key":"17_CR19","doi-asserted-by":"publisher","unstructured":"Alzoubi H, Minasi S, Gianno F et al (2022) Alternative lengthening of telomeres (ALT) and telomerase reverse transcriptase promoter methylation in recurrent adult and primary pediatric pituitary neuroendocrine tumors. Endocr Pathol. https:\/\/doi.org\/10.1007\/s12022-021-09702-0","DOI":"10.1007\/s12022-021-09702-0"},{"key":"17_CR20","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nature10833","volume":"482","author":"J Schwartzentruber","year":"2012","unstructured":"Schwartzentruber J, Korshunov A, Liu XY et al (2012) Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 482:226\u2013231. https:\/\/doi.org\/10.1038\/nature10833","journal-title":"Nature"},{"key":"17_CR21","doi-asserted-by":"publisher","first-page":"417","DOI":"10.7150\/jca.80097","volume":"14","author":"H Sun","year":"2023","unstructured":"Sun H, Chen G, Guo B et al (2023) Potential clinical treatment prospects behind the molecular mechanism of alternative lengthening of telomeres (ALT). J Cancer 14:417\u2013433","journal-title":"J Cancer"},{"key":"17_CR22","unstructured":"Strovel J, Sittampalam S, Coussens NP, Hughes M, Inglese J, Kurtz A, Andalibi A, Patton L, Austin C, Baltezor M, Beckloff M, Weingarten M, Weir S (2012\/2016) Early Drug Discovery and Development Guidelines: For Academic Researchers, Collaborators, and Start-up Companies. In: Markossian S, Grossman A, Baskir H, Arkin M, Auld D, Austin C, Baell J, Brimacombe K, Chung TDY, Coussens NP, Dahlin JL, Devanarayan V, Foley TL, Glicksman M, Gorshkov K, Grotegut S, Hall MD, Hoare S, Inglese J, Iversen PW, Lal-Nag M, Li Z, Manro JR, McGee J, Norvil A, Pearson M, Riss T, Saradjian P, Sittampalam GS, Tarselli MA, Trask OJ Jr, Weidner JR, Wildey MJ, Wilson K, Xia M, Xu X, (eds) Assay Guidance Manual [Internet]. Bethesda (MD): Eli Lilly & Company and the National Center for Advancing Translational Sciences 2004. PMID: 22553881"},{"key":"17_CR23","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1080\/17460441.2017.1308351","volume":"12","author":"GE Croston","year":"2017","unstructured":"Croston GE (2017) The utility of target-based discovery. Expert Opin Drug Discov 12:427\u2013429","journal-title":"Expert Opin Drug Discov"},{"key":"17_CR24","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/nrd.2017.111","volume":"16","author":"JG Moffat","year":"2017","unstructured":"Moffat JG, Vincent F, Lee JA et al (2017) Opportunities and challenges in phenotypic drug discovery: An industry perspective. Nat Rev Drug Discov 16:531\u2013543","journal-title":"Nat Rev Drug Discov"},{"key":"17_CR25","doi-asserted-by":"publisher","unstructured":"Lovejoy CA, Li W, Reisenweber S et al (2012) Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of Telomeres pathway. PLoS Genet 8. https:\/\/doi.org\/10.1371\/journal.pgen.1002772","DOI":"10.1371\/journal.pgen.1002772"},{"key":"17_CR26","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1093\/nar\/gkn1030","volume":"37","author":"LJ Ng","year":"2009","unstructured":"Ng LJ, Cropley JE, Pickett HA et al (2009) Telomerase activity is associated with an increase in DNA methylation at the proximal subtelomere and a reduction in telomeric transcription. Nucleic Acids Res 37:1152\u20131159. https:\/\/doi.org\/10.1093\/nar\/gkn1030","journal-title":"Nucleic Acids Res"},{"key":"17_CR27","doi-asserted-by":"publisher","first-page":"3985","DOI":"10.1016\/j.molcel.2022.09.026","volume":"82","author":"T Yadav","year":"2022","unstructured":"Yadav T, Zhang JM, Ouyang J et al (2022) TERRA and RAD51AP1 promote alternative lengthening of telomeres through an R- to D-loop switch. Mol Cell 82:3985\u20134000.e4. https:\/\/doi.org\/10.1016\/j.molcel.2022.09.026","journal-title":"Mol Cell"},{"key":"17_CR28","first-page":"4175","volume":"59","author":"TR Yeager","year":"1999","unstructured":"Yeager TR, Neumann AA, Englezou A et al (1999) Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body. Cancer Res 59:4175\u20134179","journal-title":"Cancer Res"},{"key":"17_CR29","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/nbt.1587","volume":"27","author":"JD Henson","year":"2009","unstructured":"Henson JD, Cao Y, Huschtscha LI et al (2009) DNA C-circles are specific and quantifiable markers of alternative-lengthening-of-telomeres activity. Nat Biotechnol 27:1181\u20131185. https:\/\/doi.org\/10.1038\/nbt.1587","journal-title":"Nat Biotechnol"},{"key":"17_CR30","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.ymeth.2016.08.016","volume":"114","author":"JD Henson","year":"2017","unstructured":"Henson JD, Lau LM, Koch S et al (2017) The C-Circle assay for alternative-lengthening-of-telomeres activity. Methods 114:74\u201384. https:\/\/doi.org\/10.1016\/j.ymeth.2016.08.016","journal-title":"Methods"},{"key":"17_CR31","doi-asserted-by":"publisher","unstructured":"Chen YY, Dagg R, Zhang Y et al (2021) The C-circle biomarker is secreted by alternative-lengthening-of-telomeres positive cancer cells inside exosomes and provides a blood-based diagnostic for ALT activity. Cancers 13. https:\/\/doi.org\/10.3390\/cancers13215369","DOI":"10.3390\/cancers13215369"},{"key":"17_CR32","doi-asserted-by":"publisher","unstructured":"Froney MM, Cook CR, Cadiz AM et al (2024) A first-in-class high-throughput screen to discover modulators of the alternative lengthening of telomeres (ALT) pathway. ACS Pharmacol Transl Sci. https:\/\/doi.org\/10.1021\/acsptsci.4c00251","DOI":"10.1021\/acsptsci.4c00251"},{"key":"17_CR33","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1177\/1087057111405851","volume":"16","author":"XD Zhang","year":"2011","unstructured":"Zhang XD (2011) Illustration of SSMD, z score, SSMD*, z* score, and t statistic for hit selection in RNAi high-throughput screens. J Biomol Screen 16:775\u2013785. https:\/\/doi.org\/10.1177\/1087057111405851","journal-title":"J Biomol Screen"}],"container-title":["Methods in Molecular Biology","Cancer Epigenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-5072-1_17","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T22:03:26Z","timestamp":1787695406000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-5072-1_17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9781071650714","9781071650721"],"references-count":33,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-5072-1_17","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"2 July 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}